Octreotide LAR as Maintenance Treatment for Patients With NEC

Clinical trial NCT02409849 · UNKNOWN

Trial details

NCT number: NCT02409849
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastro-entero-pancreatic Carcinoma Esophageal Neuroendocrine Carcinoma

Start date: 2015-04-01
Primary completion: 2018-11-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.